Financhill
Back

Enanta Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
28

ENTA
Enanta Pharmaceuticals

Last Price:
9.30
Seasonality Move:
15.66%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.72
Seasonality Move:
-0.57%
Sell
28
Enanta Pharmaceuticals (ENTA) is a Sell

Is Enanta Pharmaceuticals a Buy, Sell or Hold?

  • The current Enanta Pharmaceuticals [ENTA] share price is $9.31. The Score for ENTA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENTA Stock Price Chart

What is Enanta Pharmaceuticals's stock price today?

  • The Enanta Pharmaceuticals share price today is $9.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.72
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ENTA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 28.87 Sell
Chaikin Money Flow: 165985 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.99 - 12.17) Sell
Bollinger Bands (100): (10.7 - 14) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: 23717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.27 - 1.45) Sell

ENTA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.77 Sell
20-day SMA: 10.69 Sell
50-day SMA: 11.14 Sell
200-day SMA: 13.04 Sell
8-day EMA: 9.75 Sell
20-day EMA: 10.45 Sell
50-day EMA: 11.18 Sell
200-day EMA: 13.13 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.66 Buy
200-day SMA: 2.35 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.62 Sell

Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.01 per share, and an increase next year of $0.23 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Enanta Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):